| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3436018 | American Journal of Obstetrics and Gynecology | 2010 | 5 Pages |
Abstract
β-hCG level changes between days 0 and 4 after methotrexate therapy have clinical significance and predictive value. Decreasing β-hCG levels is highly predictive of treatment success. The β-hCG difference variable is a reliable predictor of success in cases with rising β-hCG levels after methotrexate therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Quyen MD, Martha MD, Katheryne MPH, Celso MD,